Sulfonylureas are used extensively for hyperglycemia management mainly in elderly, non-insulin-dependent diabetes mellitus (NIDDM) patients. This group of drugs have good effectiveness, simple dosing regimens, and relatively safe profile. On the other hand, these agents include the relatively low likelihood of achieving euglycemia, higher risk of hypoglycemia, and several negative interactions with other drugs.
As a practicing physician, you may encounter many questions related to the selection of drugs for best patient outcomes. To answer such pressing questions related to the use of sulphonylureas, Docplexus , in association with the Research Society for the Study of Diabetes in India (RSSDI), has organized an exciting Indian Diabetes League based on “ Future aspects of Sulphonylureas (SUs) in Diabetic Patients: Yes / No” 2nd November, 2020, 7:00 PM onwards . In this session,…
